FDA approves new Vertex's drug, stock halted By: CNBC.com News July 02, 2015 at 12:40 PM EDT The FDA approved the use of Vertex Pharmaceuticals' Orkambi, a drug aimed to treat patients with cystic fibrosis. Read More >> Related Stocks: Vertex Pharmaceuticals